SARS-CoV-2 specific T cell therapy (KK Women's and Children's Hospital)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSARS-CoV-2 specific T cell therapy (KK Women's and Children's Hospital)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Virus-specific T Cell therapy

Mechanisms of ActionUpdating

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySingapore

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesKk Women'S And Children'S Hospital

China Registration ClassN/A

Develop Information

Active CompaniesKk Women'S And Children'S Hospital

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A